Establishment Labs Holdings (ESTA) Share-based Compensation (2017 - 2025)
Establishment Labs Holdings' (ESTA) quarterly Share-based Compensation came in at $7.9 million in Q4 2025, down 43.9% year-on-year from $14.0 million in Q4 2024, and up 480.95% quarter-over-quarter from -$2.1 million in Q3 2025.
Establishment Labs Holdings (ESTA) Share-based Compensation (2017 - 2025) Analysis & Trends
Establishment Labs Holdings' Share-based Compensation history runs 9 years deep, the most recent figure standing at $7.9 million for Q4 2025.
- On a quarterly basis, Share-based Compensation fell 43.9% year-over-year to $7.9 million in Q4 2025; TTM through Mar 2026 was $9.0 million, a 46.28% decrease from a year earlier, with the FY2025 full-year figure at $11.4 million, down 20.75% from the prior year.
- Share-based Compensation advanced to $7.9 million in Q4 2025 per ESTA's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $14.0 million in Q4 2024 and bottomed at -$10.1 million in Q4 2022.
- The 5-year median for Share-based Compensation is $2.1 million (2021), against an average of $2.5 million.
- Across the five-year window, Share-based Compensation tumbled 12107.14% in 2021 and soared 77576.92% in 2022, its largest moves.
- Year by year, Share-based Compensation stood at $10.3 million in 2021, then tumbled by 197.86% to -$10.1 million in 2022, then soared by 134.18% to $3.5 million in 2023, then jumped by 305.97% to $14.0 million in 2024, then plunged by 43.9% to $7.9 million in 2025.
- Per Business Quant, the three latest ESTA Share-based Compensation figures stand at $7.9 million (Q4 2025), -$2.1 million (Q3 2025), and $3.2 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.86 Mn |
| Dec 31, 2025 | 7.86 Mn |
| Sep 30, 2025 | -2.06 Mn |
| Sep 30, 2025 | -2.06 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Mar 31, 2025 | 2.43 Mn |
| Dec 31, 2024 | 14.01 Mn |
| Dec 31, 2024 | 14.01 Mn |
| Sep 30, 2024 | 87,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 188,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | 3.45 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Sep 30, 2023 | 3.97 Mn |